Paolo Marchi - Concepedia

Author

Paolo Marchi

University of Sheffield ORCID

Also Known As

Marchi, P., P Marchi, P. Marchi, Paolo M Marchi, Paolo M. Marchi, Paolo Marchi

Publications

444

Citations

H-Index

Concepts

All Affiliations

University of Sheffield University of Alberta

About

Paolo Marchi is an author at University of Sheffield specializing in medicine, neurodegenerative diseases, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	219
2	Natural Sciences	2	2	43
3	Law	1	1	10
4	Public Health	1	1	10
5	Biomedical Engineering	1	1	19

Paolo Marchi

Publications

389

Citations

H-Index

Page 1

	Year	Citations
Impaired Ganglioside Metabolism in Huntington's Disease and Neuroprotective Role of GM1 Vittorio Maglione, Paolo Marchi, Alba Di Pardo, Journal of Neuroscience Neuroprotective RoleNeurodegenerative DiseasesMedicineGm1 RestoresAutophagy	2010	141
SUMOylation regulates Kv2.1 and modulates pancreatic β-cell excitability Xiao-Qing Dai, Jelena Kolic, Paolo Marchi, Journal of Cell Science	2009	87
Mutant Huntingtin induces activation of the Bcl-2/adenovirus E1B 19-kDa interacting protein (BNip3) Jenny Sassone, Clarissa Colciago, Paolo Marchi, Cell Death and Disease MitophagyMitochondrial DysfunctionMolecular BiologyCell DeathBnip3 Expression	2010	29
Patient Preference and Physician Perceptions of Patient Preference for Oral Pharmaceutical Formulations: Results from a Real-Life Survey L Mackenzie-Smith, Paolo Marchi, Helen Thorne, Inflammatory Intestinal Diseases	2018	20
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments Lucia Del Mastro, Alessandra Fabi, Mauro Mansutti, BMC Cancer	2013	19
Delivery of therapeutic AAV9 vectors via cisterna magna to treat neurological disorders Paolo Marchi, Lara Marrone, Mimoun Azzouz Trends in Molecular Medicine Gene TherapiesTranslational MedicineMedical TreatmentCisterna MagnaNeurological Disorders	2021	19
SPG15 protein deficits are at the crossroads between lysosomal abnormalities, altered lipid metabolism and synaptic dysfunction Lara Marrone, Paolo Marchi, Christopher P Webster, Human Molecular Genetics GeneticsSpg15 Protein DeficitsCell DeathLipid AccumulationLysosomal Abnormalities	2022	16
SMN-deficient cells exhibit increased ribosomal DNA damage Evangelia Karyka, Nelly Berrueta Ramirez, Christopher P Webster, Life Science Alliance ChromatinGenome InstabilityNeurodegenerative DiseasesDna DamageMotor Neuron Disease	2022	14
Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalization Joseph M. Scarrott, João Alves-Cruzeiro, Paolo Marchi, Brain Communications	2022	13
Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47 Jessica Wiseman, Joseph M. Scarrott, João Alves-Cruzeiro, EMBO Molecular Medicine	2024	11

Page 1